YTEN logo

Yield10 Bioscience (YTEN) Free Cash Flow

Annual FCF

-$10.11 M
+$1.44 M+12.49%

December 31, 2023

Summary

Performance

1-Year Change

+12.49%

3-Year Change

-15.79%

5-Year Change

-14.98%

15-Year Change

-23.22%

YTEN Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.92%
YTEN annual free cash flow is higher than 37.92% of companies in Basic Materials sector

High & Low

All-time High

-$2.31 M

3-Year Low

-$11.56 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
YTEN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
YTEN next annual earnings announcement has not yet been scheduled

OtherYTENcash flowmetrics:

Annual CFO

-$10.07 M
YTEN annual cash flow from operations is -$10.07 million

Annual CFF

$6.87 M
YTEN annual cash flow from financing activities is $6.87 million

Annual CFI

$1.95 M
YTEN annual cash flow from investing activities is $1.95 million

Annual CAPEX

$46.00 K
YTEN annual capital expenditures is $46.00 thousand

Quarterly FCF

-$574.00 K
+$329.00 K+36.43%

June 30, 2024

Summary

Performance

3-Month Change

+36.43%

1-Year Change

+78.01%

3-Year Change

+77.29%

5-Year Change

+68%

YTEN Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.28%
YTEN quarterly free cash flow is higher than 46.28% of companies in Basic Materials sector

High & Low

All-time High

-$13.00 K

3-Year Low

-$3.22 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
YTEN previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
YTEN next earnings announcement has not yet been scheduled

OtherYTENcash flowmetrics:

Quarterly CFO

-$574.00 K
YTEN quarterly cash flow from operations is -$574.00 thousand

Quarterly CFF

-$326.00 K
YTEN quarterly cash flow from financing activities is -$326.00 thousand

Quarterly CFI

$0.00
YTEN quarterly cash flow from investing activities is $0.00

Quarterly CAPEX

-
YTEN quarterly capital expenditures value is unknown

TTM FCF

-$5.82 M
+$2.52 M+30.25%

June 30, 2024

Summary

Performance

3-Month Change

+30.25%

1-Year Change

+49.17%

3-Year Change

+38.38%

5-Year Change

+33.5%

YTEN TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.19%
YTEN TTM free cash flow is higher than 37.19% of companies in Basic Materials sector

High & Low

All-time High

-$2.96 M

3-Year Low

-$11.56 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
YTEN previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
YTEN next earnings announcement has not yet been scheduled

OtherYTENcash flowmetrics:

TTM CFO

-$5.80 M
YTEN TTM cash flow from operations is -$5.80 million

TTM CFF

$3.98 M
YTEN TTM cash flow from financing activities is $3.98 million

TTM CFI

-$19.00 K
YTEN TTM cash flow from investing activities is -$19.00 thousand

TTM CAPEX

-
YTEN TTM capital expenditures value is unknown

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$10.11 M
YTEN annual free cash flow is -$10.11 million

Annual CFO

-$10.07 M
YTEN annual cash flow from operations is -$10.07 million

Annual CAPEX

$46.00 K
YTEN annual capital expenditures is $46.00 thousand

YTEN Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+12.5%+78.0%+49.2%
3 y3 years-15.8%+77.3%+38.4%
5 y5 years-15.0%+68.0%+33.5%

YTEN Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-7.1%+12.5%at high+82.2%at high+49.7%
5 y5-year-16.1%+12.5%at high+82.4%at high+49.7%
alltimeall time-338.8%+69.3%-4315.4%+95.4%-96.6%+83.5%

Yield10 Bioscience Free Cash Flow History

DateAnnualQuarterlyTTM
Jun 2024
-
-$574.00 K(-36.4%)
-$5.82 M(-30.2%)
Mar 2024
-
-$903.00 K(-47.8%)
-$8.34 M(-17.5%)
Dec 2023
-$10.11 M(-12.5%)
-$1.73 M(-33.7%)
-$10.11 M(-11.6%)
Sep 2023
-
-$2.61 M(-15.7%)
-$11.45 M(-1.0%)
Jun 2023
-
-$3.10 M(+15.7%)
-$11.56 M(+4.9%)
Mar 2023
-
-$2.68 M(-12.6%)
-$11.02 M(-4.7%)
Dec 2022
-$11.56 M(+22.4%)
-$3.06 M(+12.4%)
-$11.56 M(+4.9%)
Sep 2022
-
-$2.72 M(+6.5%)
-$11.02 M(+7.0%)
Jun 2022
-
-$2.56 M(-20.5%)
-$10.30 M(+3.9%)
Mar 2022
-
-$3.22 M(+27.3%)
-$9.92 M(+5.1%)
Dec 2021
-$9.44 M(+8.1%)
-$2.53 M(+26.2%)
-$9.44 M(+5.6%)
Sep 2021
-
-$2.00 M(-7.9%)
-$8.94 M(-0.6%)
Jun 2021
-
-$2.17 M(-20.6%)
-$8.99 M(-1.6%)
Mar 2021
-
-$2.74 M(+35.3%)
-$9.14 M(+4.7%)
Dec 2020
-$8.73 M(+0.2%)
-$2.02 M(-1.7%)
-$8.73 M(-12.4%)
Sep 2020
-
-$2.06 M(-11.4%)
-$9.97 M(+7.4%)
Jun 2020
-
-$2.32 M(-0.3%)
-$9.28 M(+6.1%)
Mar 2020
-
-$2.33 M(-28.5%)
-$8.75 M(+0.4%)
Dec 2019
-$8.71 M(-0.9%)
-$3.26 M(+138.3%)
-$8.71 M(+16.5%)
Sep 2019
-
-$1.37 M(-23.8%)
-$7.48 M(-6.1%)
Jun 2019
-
-$1.79 M(-21.9%)
-$7.96 M(-1.2%)
Mar 2019
-
-$2.30 M(+13.5%)
-$8.06 M(-8.4%)
Dec 2018
-$8.80 M(+7.2%)
-$2.02 M(+9.3%)
-$8.80 M(+1.5%)
Sep 2018
-
-$1.85 M(-2.0%)
-$8.67 M(-2.0%)
Jun 2018
-
-$1.89 M(-37.7%)
-$8.84 M(+0.4%)
Mar 2018
-
-$3.03 M(+60.2%)
-$8.81 M(+7.3%)
Dec 2017
-$8.21 M(-45.8%)
-$1.89 M(-6.7%)
-$8.21 M(-6.3%)
Sep 2017
-
-$2.03 M(+9.5%)
-$8.76 M(-23.4%)
Jun 2017
-
-$1.85 M(-23.8%)
-$11.44 M(+4.9%)
Mar 2017
-
-$2.43 M(-0.6%)
-$10.90 M(-28.1%)
Dec 2016
-$15.16 M(-32.7%)
-$2.45 M(-47.9%)
-$15.16 M(-17.3%)
Sep 2016
-
-$4.70 M(+256.8%)
-$18.33 M(+0.8%)
Jun 2016
-
-$1.32 M(-80.3%)
-$18.18 M(-18.9%)
Mar 2016
-
-$6.69 M(+18.9%)
-$22.42 M(-0.4%)
Dec 2015
-$22.52 M(-8.9%)
-$5.63 M(+23.6%)
-$22.52 M(-1.3%)
Sep 2015
-
-$4.55 M(-18.0%)
-$22.80 M(-1.3%)
Jun 2015
-
-$5.55 M(-18.2%)
-$23.10 M(+3.0%)
Mar 2015
-
-$6.79 M(+14.8%)
-$22.43 M(-9.2%)
DateAnnualQuarterlyTTM
Dec 2014
-$24.71 M(-8.6%)
-$5.91 M(+21.9%)
-$24.71 M(-2.4%)
Sep 2014
-
-$4.85 M(-0.7%)
-$25.32 M(-4.1%)
Jun 2014
-
-$4.88 M(-46.2%)
-$26.40 M(-4.1%)
Mar 2014
-
-$9.06 M(+38.9%)
-$27.52 M(+1.9%)
Dec 2013
-$27.02 M(-15.9%)
-$6.53 M(+10.0%)
-$27.02 M(-2.8%)
Sep 2013
-
-$5.93 M(-1.2%)
-$27.80 M(-1.6%)
Jun 2013
-
-$6.00 M(-29.9%)
-$28.26 M(-0.1%)
Mar 2013
-
-$8.56 M(+17.2%)
-$28.28 M(-12.0%)
Dec 2012
-$32.13 M(-1.5%)
-$7.31 M(+14.3%)
-$32.13 M(-4.7%)
Sep 2012
-
-$6.39 M(+6.1%)
-$33.70 M(-4.5%)
Jun 2012
-
-$6.02 M(-51.5%)
-$35.27 M(-0.2%)
Mar 2012
-
-$12.41 M(+39.8%)
-$35.36 M(+8.4%)
Dec 2011
-$32.63 M(-0.8%)
-$8.88 M(+11.4%)
-$32.63 M(+1.7%)
Sep 2011
-
-$7.96 M(+30.3%)
-$32.08 M(+1.8%)
Jun 2011
-
-$6.11 M(-36.9%)
-$31.50 M(-4.7%)
Mar 2011
-
-$9.68 M(+16.2%)
-$33.05 M(+0.4%)
Dec 2010
-$32.90 M(+18.5%)
-$8.33 M(+12.8%)
-$32.90 M(+4.3%)
Sep 2010
-
-$7.39 M(-3.5%)
-$31.54 M(-0.5%)
Jun 2010
-
-$7.65 M(-19.7%)
-$31.69 M(+11.0%)
Mar 2010
-
-$9.53 M(+36.8%)
-$28.55 M(+2.8%)
Dec 2009
-$27.78 M(+44.8%)
-$6.97 M(-7.6%)
-$27.78 M(+13.1%)
Sep 2009
-
-$7.54 M(+67.2%)
-$24.55 M(+3.5%)
Jun 2009
-
-$4.51 M(-48.5%)
-$23.71 M(+2.6%)
Mar 2009
-
-$8.76 M(+134.1%)
-$23.11 M(+20.4%)
Dec 2008
-$19.19 M(+23.3%)
-$3.74 M(-44.1%)
-$19.19 M(-3.6%)
Sep 2008
-
-$6.70 M(+71.6%)
-$19.91 M(+24.7%)
Jun 2008
-
-$3.90 M(-19.4%)
-$15.97 M(-2.6%)
Mar 2008
-
-$4.84 M(+8.4%)
-$16.39 M(+5.3%)
Dec 2007
-$15.56 M(+202.4%)
-$4.47 M(+62.2%)
-$15.56 M(+25.2%)
Sep 2007
-
-$2.75 M(-36.3%)
-$12.43 M(+28.3%)
Jun 2007
-
-$4.32 M(+7.5%)
-$9.69 M(+56.0%)
Mar 2007
-
-$4.02 M(+202.0%)
-$6.21 M(+20.6%)
Dec 2006
-$5.15 M(-17.8%)
-$1.33 M(>+9900.0%)
-$5.15 M(+34.9%)
Sep 2006
-
-$13.00 K(-98.5%)
-$3.82 M(+0.3%)
Jun 2006
-
-$844.00 K(-71.5%)
-$3.80 M(+28.5%)
Mar 2006
-
-$2.96 M
-$2.96 M
Dec 2005
-$6.26 M(+171.7%)
-
-
Dec 2004
-$2.31 M
-
-

FAQ

  • What is Yield10 Bioscience annual free cash flow?
  • What is the all time high annual FCF for Yield10 Bioscience?
  • What is Yield10 Bioscience annual FCF year-on-year change?
  • What is Yield10 Bioscience quarterly free cash flow?
  • What is the all time high quarterly FCF for Yield10 Bioscience?
  • What is Yield10 Bioscience quarterly FCF year-on-year change?
  • What is Yield10 Bioscience TTM free cash flow?
  • What is the all time high TTM FCF for Yield10 Bioscience?
  • What is Yield10 Bioscience TTM FCF year-on-year change?

What is Yield10 Bioscience annual free cash flow?

The current annual FCF of YTEN is -$10.11 M

What is the all time high annual FCF for Yield10 Bioscience?

Yield10 Bioscience all-time high annual free cash flow is -$2.31 M

What is Yield10 Bioscience annual FCF year-on-year change?

Over the past year, YTEN annual free cash flow has changed by +$1.44 M (+12.49%)

What is Yield10 Bioscience quarterly free cash flow?

The current quarterly FCF of YTEN is -$574.00 K

What is the all time high quarterly FCF for Yield10 Bioscience?

Yield10 Bioscience all-time high quarterly free cash flow is -$13.00 K

What is Yield10 Bioscience quarterly FCF year-on-year change?

Over the past year, YTEN quarterly free cash flow has changed by +$2.04 M (+78.01%)

What is Yield10 Bioscience TTM free cash flow?

The current TTM FCF of YTEN is -$5.82 M

What is the all time high TTM FCF for Yield10 Bioscience?

Yield10 Bioscience all-time high TTM free cash flow is -$2.96 M

What is Yield10 Bioscience TTM FCF year-on-year change?

Over the past year, YTEN TTM free cash flow has changed by +$5.63 M (+49.17%)